HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sasanka Ramanadham Selected Research

Inflammation (Inflammations)

10/2016Polarization of Macrophages toward M2 Phenotype Is Favored by Reduction in iPLA2β (Group VIA Phospholipase A2).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sasanka Ramanadham Research Topics

Disease

13Insulinoma
12/2012 - 04/2002
8Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2021 - 09/2012
4Diabetes Mellitus
09/2013 - 02/2004
3Hyperglycemia
03/2008 - 01/2002
2Brain Neoplasms (Brain Tumor)
01/2022 - 01/2020
2Glioblastoma (Glioblastoma Multiforme)
01/2022 - 01/2020
2Autoimmune Diseases (Autoimmune Disease)
11/2020 - 01/2019
2Neoplasms (Cancer)
11/2020 - 01/2020
2Glucose Intolerance
10/2020 - 07/2006
2Mitochondrial Diseases (Mitochondrial Disease)
09/2013 - 12/2008
2Insulin Resistance
05/2010 - 03/2008
2Type 2 Diabetes Mellitus (MODY)
03/2008 - 02/2004
1Nervous System Diseases (Neurological Disorders)
01/2019
1Inflammation (Inflammations)
10/2016
1Infections
05/2010
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2008
1Alzheimer Disease (Alzheimer's Disease)
12/2004

Drug/Important Bio-Agent (IBA)

14Calcium-Independent Phospholipases A2IBA
12/2012 - 04/2002
8Insulin (Novolin)FDA Link
09/2013 - 01/2002
6Phospholipases (Phospholipase)IBA
02/2015 - 02/2004
5Glucose (Dextrose)FDA LinkGeneric
10/2020 - 12/2003
5Phospholipases A2 (Phospholipase A2)IBA
01/2019 - 12/2003
4LipidsIBA
01/2020 - 05/2010
3CeramidesIBA
01/2022 - 09/2007
3CytokinesIBA
11/2020 - 03/2008
3Phospholipids (Phosphatides)FDA LinkGeneric
05/2006 - 10/2004
36- (bromomethylene)tetrahydro- 3- (1- naphthaleneyl)- 2H- pyran- 2- oneIBA
02/2005 - 02/2004
2SphingolipidsIBA
10/2021 - 01/2020
2Blood Glucose (Blood Sugar)IBA
09/2013 - 07/2006
2Protein Isoforms (Isoforms)IBA
05/2010 - 12/2003
2HIV Protease InhibitorsIBA
05/2010 - 03/2008
2SphingomyelinsIBA
12/2008 - 09/2007
2Proteins (Proteins, Gene)FDA Link
03/2008 - 12/2004
2ThapsigarginIBA
09/2007 - 02/2004
2CalciumIBA
02/2004 - 02/2004
1Acid CeramidaseIBA
01/2022
1CeramidasesIBA
01/2022
1Hydroxyl RadicalIBA
11/2020
1AcidsIBA
11/2020
1Temozolomide (Temodar)FDA LinkGeneric
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2020
1LysophospholipidsIBA
10/2016
1EicosanoidsIBA
10/2016
1Arachidonic Acid (Vitamin F)IBA
10/2016
1Oxidants (Oxidizing Agents)IBA
09/2013
1Mitochondrial Proteins (Mitochondrial Protein)IBA
09/2013
1Mitochondrial DNA (mtDNA)IBA
09/2013
1RyanodineIBA
09/2012
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
09/2012
1Lipid Bilayers (Lipid Bilayer)IBA
09/2012
1Fatty Acids (Saturated Fatty Acids)IBA
05/2010
1Ritonavir (Norvir)FDA Link
04/2009
1LopinavirFDA Link
04/2009
1Atazanavir Sulfate (Reyataz)FDA Link
04/2009
1tipranavirFDA Link
04/2009
1ColforsinIBA
12/2008
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
09/2007
1Streptozocin (Streptozotocin)FDA Link
07/2006
1Biological ProductsIBA
07/2006
1KN 93IBA
02/2005
1Amyloid (Amyloid Fibrils)IBA
12/2004
1EnzymesIBA
12/2004

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2020
1Highly Active Antiretroviral Therapy (HAART)
05/2010
1Therapeutics
05/2010